Vitamin K2 Market Analysis

  • Report ID: 4278
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Vitamin K2 Market Segmentation:

Application Segment Analysis

The nutraceuticals segment is anticipated to hold the largest vitamin K2 market size by the end of 2035 attributed to the surge in the number of people who are taking dietary supplements in the form of nutraceuticals. For instance, according to Penn State Health News in May 2024, almost 59 million Americans use some type of supplements. Additionally, there is a rise in research and development in the supplements and nutraceuticals domain. A study by the National Institutes of Health in 2021 stated that research in the field has grown with over 70,000 published articles.

Source Segment Analysis

The natural segment is projected to witness significant vitamin K2 market size in the coming decade. Various market players are making supplements of superior quality for supporting bone and heart health. For instance, in 2021, Gnosis by Lesaffre, declared the launch of a new version of vitaMK7 natural vitamin K2 with enhanced protection. The product ensures the stability of menaquinone ingredients in complex finished product formulations.

Our in-depth analysis of the vitamin K2 market includes the following segments:

Type

  • MK-7
  •  MK-4

Application

  • Nutraceutical
  • Food
  • Pharmaceuticals

Source

  • Natural
  • Synthetic

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of vitamin K2 is estimated at USD 272.55 Million.

The global vitamin K2 market size was more than USD 243.41 Million in 2025 and is anticipated to grow at a CAGR of over 13.3%, reaching USD 848.47 Million revenue by 2035.

North America vitamin K2 market is predicted to capture 36.1% share by 2035, driven by the increasing health focus and osteoporosis awareness in the region.

Key players in the market include Kappa Bioscience Group, Gnosis by Lesaffre, Koninklijke DSM N.V, Pfizer Inc., Viridis BioPharma Pvt. Ltd., DuPont de Nemours, Inc., Seebio Biotech (Shanghai) Co., Ltd., GeneFerm Biotechnology Co., Ltd., Kyowa Hakka Bio Co., Ltd., International Flavors & Fragrances Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos